Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0MP7Z
|
||||
Former ID |
DNC013155
|
||||
Drug Name |
Dmt-Pro-Phe-D-2-Nal-NH2
|
||||
Indication | Discovery agent | Investigative | [528646] | ||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528646] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528646] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.